Literature DB >> 3194891

Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis.

T Matsuo1, Y Chikahira, T Yamada, K Nakao, S Ueshima, O Matsuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3194891     DOI： 10.1016/0049-3848(88)90095-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

Review 1.  Argatroban.

Authors:  K McKeage; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

Review 3.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.

Authors:  Rebecca L Morgan; Vahid Ashoorion; Adam Cuker; Housne Begum; Stephanie Ross; Nina Martinez; Beng H Chong; Lori A Linkins; Theodore E Warkentin; Wojtek Wiercioch; Robby Nieuwlaat; Holger Schünemann; Nancy Santesso
Journal:  Blood Adv       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.